The ROE as of December 2025 (TTM) for Gyre Therapeutics, Inc. (GYRE) is 15.20%

According to Gyre Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 15.20%. This represents a change of 352.63% compared to the average of 3.36% of the last 4 quarters.

Gyre Therapeutics, Inc. (GYRE) Historical ROE (quarterly & annually)

How has GYRE ROE performed in the past?

The mean historical ROE of Gyre Therapeutics, Inc. over the last ten years is -0.03%. The current 15.20% ROE has changed -49950.39% with respect to the historical average. Over the past ten years (40 quarters), GYRE's ROE was at its highest in in the September 2023 quarter at 113.05%. The ROE was at its lowest in in the December 2023 quarter at -107.18%.

Gyre Therapeutics, Inc. (GYRE) ROE by Quarter and Year

Discovering the peaks and valleys of Gyre Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Gyre Therapeutics, Inc. (GYRE) Average ROE

How has GYRE ROE performed in the past?

The current ROE of Gyre Therapeutics, Inc. (GYRE) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Gyre Therapeutics, Inc. (GYRE) ROE vs. Peers

How is GYRE’s ROE compared to its peers?

Gyre Therapeutics, Inc.’s ROE is greater than Anavex Life Sciences Corp. (-45.67%), greater than Erasca, Inc. (-31.19%), less than CytomX Therapeutics, Inc. (44.49%), greater than MBX Biosciences, Inc. Common Stock (-29.28%), greater than MoonLake Immunotherapeutics (-41.61%), greater than Astria Therapeutics, Inc. (-38.63%), less than Keros Therapeutics, Inc. (9.51%), greater than MeiraGTx Holdings plc (-1065.47%), greater than Iovance Biotherapeutics, Inc. (-52.87%), greater than ArriVent BioPharma, Inc. Common Stock (-55.48%),

Build a custom stock screener for Gyre Therapeutics, Inc. (GYRE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gyre Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gyre Therapeutics, Inc. (GYRE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gyre Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.